pcDNA3 H2B-mIFP T2A Mpro (wt) Citations (2)

Originally described in: FlipGFP-based activity reporter of SARS-CoV-2 main protease Mpro
Unpublished

---

Articles Citing pcDNA3 H2B-mIFP T2A Mpro (wt)

Articles
Design and synthesis of isatin derivatives as effective SARS-CoV-2 3CL protease inhibitors. Bao HL, Tu G, Yue Q, Liu P, Zheng HL, Yao XJ. Chem Biol Drug Des. 2023 Oct;102(4):857-869. doi: 10.1111/cbdd.14296. Epub 2023 Aug 10. PubMed
Inhibitory effect of [6]-shogaol against 3CLpro activity and SARS-CoV-2 infection. Tanikawa T, Hayashi T, Kiba Y, Kamauchi H, Someya Y, Kitamura M. BMC Complement Med Ther. 2025 Oct 17;25(1):385. doi: 10.1186/s12906-025-05094-4. PubMed

If you have published an article using this material, please email us at to have your article added to this page.